Pages that link to "Q36989259"
Jump to navigation
Jump to search
The following pages link to Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development. (Q36989259):
Displaying 50 items.
- Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria (Q21143739) (← links)
- Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine (Q24202900) (← links)
- Sub-Saharan red cell antigen phenotypes and glucose-6-phosphate dehydrogenase deficiency variants in French Guiana (Q24570079) (← links)
- Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date (Q26741307) (← links)
- Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria (Q28265711) (← links)
- The impact of phenotypic and genotypic G6PD deficiency on risk of plasmodium vivax infection: a case-control study amongst Afghan refugees in Pakistan (Q28474079) (← links)
- High risk of severe anaemia after chlorproguanil-dapsone artesunate antimalarial treatment in patients with G6PD (A-) deficiency (Q28474365) (← links)
- Glucose-6-phosphate dehydrogenase deficiency in an endemic area for malaria in Manaus: a cross-sectional survey in the Brazilian Amazon (Q28475311) (← links)
- Glucose-6-Phosphate Dehydrogenase Deficiency and Haemoglobin Drop after Sulphadoxine-Pyrimethamine Use for Intermittent Preventive Treatment of Malaria during Pregnancy in Ghana - A Cohort Study (Q28547654) (← links)
- Activity of herbal medicines on Plasmodium falciparum gametocytes: Implications for Malaria transmission in Ghana (Q28550911) (← links)
- G6PD deficiency in Latin America: systematic review on prevalence and variants (Q29353696) (← links)
- Tackling the malaria problem in the South-East Asia Region: need for a change in policy? (Q30597566) (← links)
- The challenges of introducing routine G6PD testing into radical cure: a workshop report (Q30666192) (← links)
- Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine (Q33400434) (← links)
- Resistance to therapies for infection by Plasmodium vivax (Q33481576) (← links)
- Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility (Q33507529) (← links)
- Nutritional status of young children with inherited blood disorders in western Kenya (Q33588574) (← links)
- Safety of 8-aminoquinolines given to people with G6PD deficiency: protocol for systematic review of prospective studies (Q33626090) (← links)
- Glucose-6-phosphate dehydrogenase deficiency in people living in malaria endemic districts of Nepal (Q33721887) (← links)
- Irreversible AE1 tyrosine phosphorylation leads to membrane vesiculation in G6PD deficient red cells (Q33796703) (← links)
- G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon (Q33801271) (← links)
- In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals (Q33826283) (← links)
- Malaria in Brazil, Colombia, Peru and Venezuela: current challenges in malaria control and elimination (Q33870033) (← links)
- Malaria rapid diagnostic tests: Plasmodium falciparum infections with high parasite densities may generate false positive Plasmodium vivax pLDH lines (Q34025937) (← links)
- Uncertainty in mapping malaria epidemiology: implications for control (Q34030351) (← links)
- Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial (Q34164652) (← links)
- Elimination therapy for the endemic malarias (Q34194828) (← links)
- The reality of using primaquine (Q34478012) (← links)
- Primaquine: the risks and the benefits (Q34503631) (← links)
- Operational strategies to achieve and maintain malaria elimination (Q34568019) (← links)
- Methemoglobinemia caused by 8-aminoquinoline drugs: DFT calculations suggest an analogy to H4B's role in nitric oxide synthase. (Q34757973) (← links)
- A High-Throughput Screen Targeting Malaria Transmission Stages Opens New Avenues for Drug Development (Q34833899) (← links)
- Enantioselective metabolism of primaquine by human CYP2D6. (Q34994945) (← links)
- Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia (Q35031434) (← links)
- Chemotherapeutics challenges in developing effective treatments for the endemic malarias (Q35095657) (← links)
- Plasmodial sugar transporters as anti-malarial drug targets and comparisons with other protozoa (Q35102950) (← links)
- Design and Synthesis of Novel Hybrid Molecules against Malaria (Q35103178) (← links)
- G6PD deficiency in male individuals infected by Plasmodium vivax malaria in the Brazilian Amazon: a cost study (Q35237781) (← links)
- Predicting the Kinetic Properties Associated with Redox Imbalance after Oxidative Crisis in G6PD-Deficient Erythrocytes: A Simulation Study (Q35250817) (← links)
- Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trials (Q35283214) (← links)
- Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells (Q35328856) (← links)
- Evaluation of the diagnostic accuracy of CareStart G6PD deficiency Rapid Diagnostic Test (RDT) in a malaria endemic area in Ghana, Africa (Q35464096) (← links)
- Review: Improving the Therapeutic Index of 8-Aminoquinolines by the Use of Drug Combinations: Review of the Literature and Proposal for Future Investigations (Q35576016) (← links)
- Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency (Q35754020) (← links)
- A Web Server and Mobile App for Computing Hemolytic Potency of Peptides (Q38638729) (← links)
- The Redox Cycler Plasmodione Is a Fast-Acting Antimalarial Lead Compound with Pronounced Activity against Sexual and Early Asexual Blood-Stage Parasites (Q36051237) (← links)
- Prevalence of G6PD deficiency in selected populations from two previously high malaria endemic areas of Sri Lanka (Q36267671) (← links)
- Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group (Q36337171) (← links)
- Analysis of G6PD enzyme deficiency in Saudi population (Q36493534) (← links)
- Study protocol for a randomised controlled double-blinded trial of the dose-dependent efficacy and safety of primaquine for clearance of gametocytes in children with uncomplicated falciparum malaria in Uganda (Q36730218) (← links)